# Persantine: Variation in Response Trial

> **NCT00763009** · PHASE4 · TERMINATED · sponsor: **UConn Health** · enrollment: 8 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** dipyridamole

## Key facts

- **NCT ID:** NCT00763009
- **Lead sponsor:** UConn Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Limited numbers of patients qualified for trial
- **Last updated:** 2018-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763009, "Persantine: Variation in Response Trial". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00763009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*